Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Deal Diamedica Tax Free* Losses can exceed
your initial deposit
*subject to change and depends on individual circumstances.

Diamedica is a biotechnology company focused on the development of treatments for Type 2 diabetes. The Company's lead candidate, DM-71, is in Phase II clinical studies to determine its effectiveness as compared to a placebo treatment.

Additional Information
Market: TSX-V
Sector: Pharmaceuticals & Biotechnology
EPIC: DMA
Latest Price: C$0.62  (0,00%)
52-week High: C$1.49
52-week Low: C$0.58
Market Cap: C$38.46M
1 year chart
Deal DMA Tax Free*
*subject to change and depends on individual circumstances.
1 day chart
Advertisement